Skip to main content

Table 1 Characteristics of the eligible studies

From: A meta-analysis of the proportion of animal Salmonella isolates resistant to drugs used against human salmonellosis in Ethiopia

       Number positive (%)
Author Year Location Host Ni Amp Sxt Chl Cro Cip MDR
[17] 1999-2000 DZ Ct 25 13 (52) 1 (4) 0 (0) 0 (0) 0 (0) 13 (52)
[18]a 2001-2002 DJ Cm 116 28 (24.14) 24 (20.69) 4 (3.45) 2 (1.72) 0 (0) 33 (28.45)
[19] 2003-2004 AM Sg 22 4 (18.18) 2 (9.09) 1 (4.55) 0 (0) 0 (0) 4 (18.18)
[12] 2004-2005 DZ Pg 94 2 (2.13) 1 (1.06) 0 (0) 0 (0) 30 (31.91) 66 (70.21)
[13]b 2004-2005 AA Pg 173 8 (4.62) 2 (1.16) 2 (1.16) 0 (0) 7 (4.05) 55 (31.79)
[20]c 2005-2006 DZ Ct 75 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 3 (4)
[21] 2006-2007 BD Ct 28 2 (7.14) Nt 1 (3.57) Nt Nt 3 (10.71)
[22] 2010 AA Dc 21 21 (100) 0 (0) 2 (9.52) 0 (0) 0 (0) 14 (66.67)
  1. AA = Addis Ababa; AM = Addis Ababa and Modjo; Amp = ampicillin; BD = Bahir Dar; Chl = chloramphenicol; Cip = ciprofloxacin; Cm = slaughtered camels; Cro = ceftriaxone; Ct = slaughtered cattle; Dc = dairy cattle; DJ = Diredawa and JiJiga; DZ = Debrezeit; MDR = multi-drug resistant; Ni = number of tested isolates; Nt = not tested; Pg = slaughtered pigs; Sg = slaughtered sheep and goats; Sxt = co-trimoxazole.
  2. aData on ceftiofur was substituted for ceftriaxone.
  3. bThe numbers of co-trimoxazole, chloramphenicol and ciprofloxacin resistant isolates was extracted from the narrative part of the results and discussion section.
  4. cIsolates from holding pens were excluded.